Citizens Business Bank’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-928
| Closed | -$708K | – | 146 |
|
|
2025
Q3 | $708K | Buy |
+928
| New | +$691K | 0.12% | 90 |
|
|
2024
Q4 | – | Sell |
-725
| Closed | -$642K | – | 111 |
|
|
2024
Q3 | $642K | Sell |
725
-349
| -32% | -$314K | 0.13% | 83 |
|
|
2024
Q2 | $972K | Buy |
1,074
+120
| +13% | +$96K | 0.21% | 73 |
|
|
2024
Q1 | $742K | Sell |
954
-139
| -13% | -$98.9K | 0.15% | 79 |
|
|
2023
Q4 | $637K | Sell |
1,093
-335
| -23% | -$196K | 0.14% | 78 |
|
|
2023
Q3 | $767K | Sell |
1,428
-273
| -16% | -$141K | 0.18% | 74 |
|
|
2023
Q2 | $798K | Buy |
1,701
+927
| +120% | +$389K | 0.18% | 72 |
|
|
2023
Q1 | $266K | Buy |
774
+103
| +15% | +$34.7K | 0.06% | 97 |
|
|
2022
Q4 | $245K | Buy |
671
+34
| +5% | +$12.1K | 0.06% | 111 |
|
|
2022
Q3 | $206K | Sell |
637
-131
| -17% | -$41.5K | 0.05% | 109 |
|
|
2022
Q2 | $249K | Buy |
768
+5
| +0.7% | +$1.5K | 0.04% | 227 |
|
|
2022
Q1 | $219K | Buy |
+763
| New | +$196K | 0.03% | 238 |
|
|
2019
Q1 | – | Sell |
-6,217
| Closed | -$719K | – | 254 |
|
|
2018
Q4 | $719K | Sell |
6,217
-6,944
| -53% | -$776K | 0.14% | 172 |
|
|
2018
Q3 | $1.41M | Sell |
13,161
-8,400
| -39% | -$840K | 0.24% | 113 |
|
|
2018
Q2 | $1.84M | Sell |
21,561
-5,623
| -21% | -$462K | 0.32% | 76 |
|
|
2018
Q1 | $2.1M | Buy |
27,184
+11,509
| +73% | +$927K | 0.37% | 69 |
|
|
2017
Q4 | $1.32M | Buy |
15,675
+8,000
| +104% | +$681K | 0.22% | 123 |
|
|
2017
Q3 | $657K | Buy |
7,675
+400
| +5% | +$32.8K | 0.11% | 184 |
|
|
2017
Q2 | $599K | Hold |
7,275
| – | – | 0.1% | 188 |
|
|
2017
Q1 | $612K | Sell |
7,275
-5,100
| -41% | -$408K | 0.1% | 186 |
|
|
2016
Q4 | $910K | Sell |
12,375
-225
| -2% | -$16.8K | 0.16% | 151 |
|
|
2016
Q3 | $1.01M | Sell |
12,600
-500
| -4% | -$40K | 0.19% | 135 |
|
|
2016
Q2 | $1.03M | Sell |
13,100
-300
| -2% | -$22.6K | 0.19% | 133 |
|
|
2016
Q1 | $965K | Sell |
13,400
-1,520
| -10% | -$115K | 0.18% | 142 |
|
|
2015
Q4 | $1.26M | Buy |
14,920
+1,000
| +7% | +$83K | 0.24% | 105 |
|
|
2015
Q3 | $1.17M | Sell |
13,920
-916
| -6% | -$77.3K | 0.22% | 114 |
|
|
2015
Q2 | $1.24M | Sell |
14,836
-1,132
| -7% | -$86.3K | 0.22% | 121 |
|
|
2015
Q1 | $1.16M | Sell |
15,968
-1,095
| -6% | -$78K | 0.2% | 126 |
|
|
2014
Q4 | $1.18M | Hold |
17,063
| – | – | 0.21% | 120 |
|
|
2014
Q3 | $1.11M | Sell |
17,063
-791
| -4% | -$50.1K | 0.21% | 131 |
|
|
2014
Q2 | $1.11M | Sell |
17,854
-300
| -2% | -$17.9K | 0.21% | 136 |
|
|
2014
Q1 | $1.07M | Buy |
+18,154
| New | +$1.01M | 0.21% | 142 |
|
Other funds holding LLY
Citizens Business Bank's LLY Position: Q4 2025 in Review
Citizens Business Bank sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 928 shares — an estimated $708K sold.
Citizens Business Bank first reported a position in LLY in Q1 2014 and held it in 32 quarters. The position peaked at $2.1M in Q1 2018. 4,441 funds tracked by Wall St. Rank hold LLY as of Q4 2025.
- Citizens Business Bank reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
- Citizens Business Bank sold 928 Eli Lilly shares in Q4 2025, an estimated $708K.
- Citizens Business Bank first reported a position in Eli Lilly in Q1 2014 and held it in 32 quarters.
- Citizens Business Bank's Eli Lilly position peaked at $2.1M in Q1 2018.
- 4,441 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.
Based on Citizens Business Bank's 13F filing for Q4 2025, filed 2 Feb 2026.